drugset / Trial / NCT02545972

Once-a-day Tacrolimus Conversion Study: The OneTAC Trial

NCT02545972 ↗

Phase 4 Unknown 100 enrolled Newark Beth Israel Medical Center
NaSingle-groupOpen-labelTreatment

Summary

This study investigates the use of tacrolimus extended release in stable patients who have undergone a heart transplant. All patients will receive the study medication free of charge for the 1 year duration of the study.

Timeline

Start
2016-02
Primary completion
2018-11
Completion
2019-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule — —

Indications